Relationship between skeletal muscle insulin resistance, insulin-mediated glucose disposal, and insulin binding. Effects of obesity and body fat topography.

Abstract

Abstract. Skeletal muscle sensitivity and responsiveness to insulin and their relationship to overall glucose disposal and insulin binding were determined in 89 premenopausal women of varying body fat topography (waist/hips girth ratio [WHR] 0.64-1.02) and obesity level (percentage of ideal body weight 92-230). As a marker of insulin action, the percentage of total glycogen synthase present in the I form (glucose-6-phosphate independent) was measured in quadriceps muscle biopsies. The increase in percentage of synthase I 1 h after oral glucose loading was not significantly different between nonobese and obese weight-matched subgroups of increasing WHR, but this response was maintained at the expense of increasing plasma insulin levels as the WHR rose. The increase in percentage of synthase I in response to submaximal steady state plasma insulin (SSPI) of -I100 gU/ml achieved by the infusion of somatostatin, insulin, and glucose, however, was significantly lower in obese than in nonobese subjects, and was inversely correlated with WHR. The increase in percentage of synthase I correlated inversely with the steady state plasma glucose (SSPG) concentration, which is an index of the efficiency of overall glucose disposal, and directly with insulin binding to circulating monocytes. Insulin binding also correlated inversely with WHR and with fasting plasma insulin levels. When obese subjects were separated into three weight-matched subgroups on the basis of increasing WHR, significant

Peroxisome proliferator activated receptor gamma activity is low in mature primary human visceral adipocytes

“…The regional distribution of fat mass affects both the sensitivity to insulin and prognosis of cardiovascular disease in humans [1]. The male abdominal fat accumulation pattern is associated with high levels of NEFA in plasma, development of type 2 diabetes, hypertension and dyslipidaemia, i.e.…”

Abdominal adiposity values associated with established body mass indexes in white, black and hispanic Americans. A study from the Third National Health and Nutrition Examination Survey

“…9,10 Second, elevated free testosterone and reduced sex-hormone-binding globulin may promote increased abdominal adiposity and reduce fractional hepatic extraction of insulin. 11 Thus, the connection of adiposity with CVD may be due to enlarged visceral fat depots discharging free fatty acids into the portal and systemic circulation. 9 ± 11 Adequate assessment of abdominal adiposity requires imaging techniques, such as computed tomography and magnetic resonance.…”

Effect of insulin therapy on body fat distribution in NIDDM patients with secondary sulfonylurea failure: a preliminary report

“…Even NIDDM patients with adequate dietary control can gradually become unresponsive to oral hypoglycemic agents. Reportedly, 14.7% of NIDDM patients ultimately require insulin therapy due to secondary sulfonylurea failure (Evans et al, 1984).…”